16th November 2026
3 minute read
Categorised under:
Industry News

Beyond the Operating Theatre: How Collaboration is Shaping the Future of Ophthalmology

The future of ophthalmology depends on more than advances in surgical technology. It relies on developing skilled clinicians, sharing expertise and creating opportunities for innovation that ultimately benefit patients. 

At SpaMedica, we’re committed to supporting this through our investment in surgical training, our European network of clinical expertise and our partnerships with industry. 

Investing in the next generation 

As the UK’s largest independent provider of NHS cataract surgery, we recognise the important role we play in supporting the next generation of ophthalmic surgeons. 

By providing valuable surgical experience, clinical supervision and opportunities for development, we’re helping trainees build the skills and confidence needed to deliver high-quality patient care.

The impact of this investment is reflected in our trainee outcomes. Data shared by our Chief Medical Officer, Dr Alexander Silvester, demonstrated that:

  • 96% of patients operated on by SpaMedica trainees achieved driving-standard vision or better, compared with a Royal College benchmark of 95%. 
  • 94% of patients achieved refractive outcomes within one dioptre, compared with a Royal College benchmark of 85%.

These results demonstrate the importance of providing trainees with the right environment, experience and support to develop their surgical skills. 

Sharing expertise across Europe 

As part of Veonet, SpaMedica benefits from working alongside ophthalmology teams across Europe, creating opportunities to share knowledge, learn from different approaches and develop clinical best practice. 

A great example is the SpaMedica Training Award, presented at ESCRS 2026. The award provides a selected trainee with a fully funded observership of up to 10 nights at a Veonet hospital in a European country of their choice, offering valuable exposure to different ophthalmic specialities and clinical approaches. 

Our involvement also extends to clinical leadership, with Dr Alexander Silvester chairing the Veonet European Medical Board, which brings together expertise from across the group to support shared clinical standards and best practice. 

Driving innovation through partnership 

Our ongoing partnership with Rayner plays an important role in supporting clinical education and the development of ophthalmic technology. 

Through collaboration on intraocular lens technology, including evaluation of Rayner’s Galaxy lens and its newer hydrophobic version, we can explore new developments and gather valuable clinical experience. 

Rayner also supports education for SpaMedica surgeons and in-house optometrists, helping teams understand different lens technologies, their benefits and limitations, and the importance of selecting the most appropriate option for each patient. 

Patient experience is equally important. Through Rayner’s RayPRO platform, patients can share feedback on their visual outcomes following surgery, giving clinicians a broader understanding of whether expectations have been met. 

Working together for better outcomes 

From developing future surgeons to sharing expertise across Europe and embracing advances in technology, collaboration is central to our approach to ophthalmic care. 

We’re proud of the work taking place across SpaMedica, Veonet and Rayner, and remain committed to investing in people, supporting clinical 

Find out more: Our Chief Medical Officer, Dr Alexander Silvester, recently discussed SpaMedica’s approach to ophthalmic training and collaboration in The Ophthalmologist. 

Read the full feature: Training Better Surgeons Across Europe

Did you find what you were looking for?

Thank you for feedback